Who can be vaccinated？ Where to vaccinate？ Eleven authoritative answers about COVID-19 vaccine!
The State Council Joint Prevention and Control Mechanism held a press conference on the morning of 19th to introduce the vaccination work of key population in Covid-19. Who can be vaccinated? Where to vaccinate? What should I do if there is an adverse reaction? Let’s pay attention to these 11 important issues!
About vaccination
Who can be vaccinated?
At present, the vaccination strategy is to implement vaccination nationwide according to the "two-step" plan.
The first step is to vaccinate some key groups, including those who are engaged in imported cold chain, port quarantine, ship pilotage, air crew, fresh market, public transportation, medical disease control and other staff with high infection risk, and those who go to work or study in medium-high risk countries or regions.
In the second step, more vaccines will be put into use with the conditional approval of vaccines for marketing or the gradual increase of vaccine output. By carrying out vaccination in an orderly manner, eligible people can achieve "should take all the answers".
Where to vaccinate?
1 vaccination units are located in the area of health service centers, township hospitals or general hospitals. All localities will promptly announce the inoculation sites and units that can be vaccinated within their jurisdiction, including locations and service hours.
2. If vaccination involves centralized units, some temporary vaccination sites will be set up to provide services at home. Inoculation conditions should be strictly regulated.
3. You can consult the local health administrative departments or disease prevention and control institutions in your jurisdiction and pay attention to the relevant information release platform.
4. Reminder: Be sure to follow the arrangement and reminder of the local notice, such as carrying your ID card, doing personal protection, and providing physical condition voluntarily.
How about the price?
The final pricing is based on cost. The price of this vaccine will change with the expansion of production scale and use scale, and a corresponding price mechanism will be formed after the vaccine is approved for conditional marketing.
When can the general public start vaccination?
After the outbreak of COVID-19, China laid out five technical routes to promote vaccine research and development. So far, according to the statistics of the World Health Organization, the vaccines that we have entered into clinical trials and entered into phase III clinical trials are in the first phalanx in the world. Because China has done a good job in epidemic prevention and control, China does not have the conditions to carry out phase III clinical trials, so our five vaccines entering phase III clinical trials are all phase III clinical trials carried out abroad. The countries and regions where we have cooperated in Phase III clinical trials are not or mostly not the countries and regions with the highest epidemic situation in the world at present, so the speed of obtaining the cases needed in Phase III clinical trials is naturally not the fastest, which is also in line with scientific laws. As far as the current situation is concerned, our fast-moving vaccine has obtained the number of cases needed in the mid-term of phase III clinical trials, and has been rolling to provide relevant materials to National Medical Products Administration recently.
After the data is uncovered, the relevant data will be released to the public in time. If the data meet the corresponding standards, the State Drug Administration will approve the conditional listing or listing, and our vaccine will be popularized faster and the output will be increased faster, because we are ready for mass production.
About adverse reactions
Will there be any adverse reactions?
Common adverse reactions mainly include: headache and fever, local redness at the inoculation site, or lumps. Some people have common adverse reactions such as cough, loss of appetite, vomiting and diarrhea.
What should I do if there is an adverse reaction?
1. Inoculation units and medical personnel involved in medical treatment will receive technical training, and they can only take up their posts after passing the training. For common adverse reactions, they can be quickly identified and disposed of.
2. The secondary hospital will be responsible for the medical security work of several inoculation units in the responsibility area, send experienced emergency personnel, carry necessary rescue equipment and medicines, and provide stagnation protection at the inoculation point. Once the situation occurs, it can be disposed of in time. When a serious abnormal reaction occurs that needs to be dealt with, on the one hand, 120 ambulances should be transported quickly, and on the other hand, the corresponding superior hospital should open a green channel to provide multidisciplinary diagnosis and treatment.
3. Reminder: According to past experience, adverse reactions often appear within 30 minutes after vaccination. Inoculators should stay at the inoculation site for 30 minutes after inoculation. After 30 minutes, there is no problem to go home. After returning home, you have symptoms related to adverse reactions, so you should seek medical attention in time. Pay attention to diet and rest, keep the inoculation site clean and dry, and let the body function return to normal as soon as possible.
Will serious adverse reactions be compensated?
The identification and compensation of rare serious adverse reactions in vaccination in China has actually formed a relatively perfect management mechanism and system. If there are serious adverse reactions in the vaccination work in COVID-19 this time, all localities will deal with them according to the existing relevant principles.
About the validity period
How long is it valid?
1. The virus was discovered less than a year ago, so it is too early to say how long this vaccine can be protected, and we can’t draw this conclusion.
2. At present, the evidence suggests that there is basically no doubt that the vaccine protection period is more than half a year as required by WHO regulations.
Do you need a dozen a year like the flu vaccine?
1. Influenza vaccines need to be adjusted at any time because of virus variation and different subtypes that are prevalent every year.
2. It should be said that COVID-19 vaccine does not exist for half a year or needs to be vaccinated again once a year. It is unlikely to be more optimistic.
3. Reminder: After vaccination with COVID-19 vaccine, we are still required to maintain personal protective measures, including wearing masks, keeping social distance and washing hands frequently. So far, no vaccine has said that the protection rate has reached 100%. And especially in the case that group immunization has not been established at present, we suggest that even after vaccination, these protective measures will not be reduced to better protect everyone’s safety.
About the safety and effect of vaccine
Is the vaccine safe?
1. From July to now, on the premise of voluntariness, knowledge and consent, emergency vaccination has been carried out for high-risk exposed people. Up to now, more than 1 million doses of COVID-19 vaccine have been completed, and no serious adverse reactions have occurred.
2. Among them, more than 60,000 people went to overseas high-risk areas, and there were no reports of serious infections.
3. From some cases of cluster infection collected by people who went abroad, it can be seen that there are significant differences in infection risk and infection degree between those who were vaccinated and those who were not vaccinated.
4. The research shows that there are no serious security risks.
Does the virus mutate? Does it affect the vaccine effect?
1. The current research results show that the variation of this virus is within a normal range, and its influence on the vaccine effect has not been seen.
2. Whether there will be a big mutation in the later stage of the virus, whether from the World Health Organization, relevant institutions in various countries, or vaccine companies, will continue to pay attention and continue to conduct research.